APO RESEARCH · REPORT
Urokinase
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Product & engineering
Understand the product.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Selected research
Market Structure
Global Urokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.
This report provides an overview of the global Urokinase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Urokinase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Urokinase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Urokinase market size, projected growth trends, production technologies, key applications, and end-use industries.
Urokinase Segment by Company
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Urokinase Segment by Type
Urokinase Powder
Urokinase Solution
Urokinase Segment by Application
Hospital
Clinic
Others
Urokinase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Urokinase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Urokinase Powder
- Urokinase Solution
Applications
- Hospital
- Clinic
- Others
Companies covered
- Syner-Med
- Wanhua Biochem
- Jiangxi Haoran Bio-Pharma
- Jiangsu Aidea Pharmaceutical
- Techpool
- Microbic Biosystems
- LIVZON
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Urokinase Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Urokinase Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Urokinase Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Urokinase Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Urokinase Market Dynamics
- 2.1 Urokinase Industry Trends
- 2.2 Urokinase Industry Drivers
- 2.3 Urokinase Industry Opportunities and Challenges
- 2.4 Urokinase Industry Restraints
3 Urokinase Market by Manufacturers
- 3.1 Global Urokinase Revenue by Manufacturers (2021-2026)
- 3.2 Global Urokinase Sales by Manufacturers (2021-2026)
- 3.3 Global Urokinase Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Urokinase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Urokinase Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Urokinase Manufacturers, Product Type & Application
- 3.7 Global Urokinase Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Urokinase Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Urokinase Players Market Share by Revenue in 2025
- 3.8.3 2025 Urokinase Tier 1, Tier 2, and Tier 3
4 Urokinase Market by Type
- 4.1 Urokinase Type Introduction
- 4.1.1 Urokinase Powder
- 4.1.2 Urokinase Solution
- 4.2 Global Urokinase Sales by Type
- 4.2.1 Global Urokinase Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Urokinase Sales by Type (2021-2032)
- 4.2.3 Global Urokinase Sales Market Share by Type (2021-2032)
- 4.3 Global Urokinase Revenue by Type
- 4.3.1 Global Urokinase Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Urokinase Revenue by Type (2021-2032)
- 4.3.3 Global Urokinase Revenue Market Share by Type (2021-2032)
5 Urokinase Market by Application
- 5.1 Urokinase Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Urokinase Sales by Application
- 5.2.1 Global Urokinase Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Urokinase Sales by Application (2021-2032)
- 5.2.3 Global Urokinase Sales Market Share by Application (2021-2032)
- 5.3 Global Urokinase Revenue by Application
- 5.3.1 Global Urokinase Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Urokinase Revenue by Application (2021-2032)
- 5.3.3 Global Urokinase Revenue Market Share by Application (2021-2032)
6 Global Urokinase Sales by Region
- 6.1 Global Urokinase Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Urokinase Sales by Region (2021-2032)
- 6.2.1 Global Urokinase Sales by Region (2021-2026)
- 6.2.2 Global Urokinase Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Urokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Urokinase Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Urokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Urokinase Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Urokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Urokinase Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Urokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Urokinase Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Urokinase Revenue by Region
- 7.1 Global Urokinase Revenue by Region
- 7.1.1 Global Urokinase Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Urokinase Revenue by Region (2021-2026)
- 7.1.3 Global Urokinase Revenue by Region (2027-2032)
- 7.1.4 Global Urokinase Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Urokinase Revenue (2021-2032)
- 7.2.2 North America Urokinase Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Urokinase Revenue (2021-2032)
- 7.3.2 Europe Urokinase Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Urokinase Revenue (2021-2032)
- 7.4.2 Asia-Pacific Urokinase Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Urokinase Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Urokinase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Syner-Med
- 8.1.1 Syner-Med Company Information
- 8.1.2 Syner-Med Business Overview
- 8.1.3 Syner-Med Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Syner-Med Urokinase Product Portfolio
- 8.1.5 Syner-Med Recent Developments
- 8.2 Wanhua Biochem
- 8.2.1 Wanhua Biochem Company Information
- 8.2.2 Wanhua Biochem Business Overview
- 8.2.3 Wanhua Biochem Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Wanhua Biochem Urokinase Product Portfolio
- 8.2.5 Wanhua Biochem Recent Developments
- 8.3 Jiangxi Haoran Bio-Pharma
- 8.3.1 Jiangxi Haoran Bio-Pharma Company Information
- 8.3.2 Jiangxi Haoran Bio-Pharma Business Overview
- 8.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio
- 8.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
- 8.4 Jiangsu Aidea Pharmaceutical
- 8.4.1 Jiangsu Aidea Pharmaceutical Company Information
- 8.4.2 Jiangsu Aidea Pharmaceutical Business Overview
- 8.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio
- 8.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
- 8.5 Techpool
- 8.5.1 Techpool Company Information
- 8.5.2 Techpool Business Overview
- 8.5.3 Techpool Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Techpool Urokinase Product Portfolio
- 8.5.5 Techpool Recent Developments
- 8.6 Microbic Biosystems
- 8.6.1 Microbic Biosystems Company Information
- 8.6.2 Microbic Biosystems Business Overview
- 8.6.3 Microbic Biosystems Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Microbic Biosystems Urokinase Product Portfolio
- 8.6.5 Microbic Biosystems Recent Developments
- 8.7 LIVZON
- 8.7.1 LIVZON Company Information
- 8.7.2 LIVZON Business Overview
- 8.7.3 LIVZON Urokinase Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 LIVZON Urokinase Product Portfolio
- 8.7.5 LIVZON Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Urokinase Value Chain Analysis
- 9.1.1 Urokinase Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Urokinase Production Mode & Process
- 9.2 Urokinase Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Urokinase Distributors
- 9.2.3 Urokinase Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst